立達信(605365.SH):產品遠銷主要包括北美、歐洲、日本以及東南亞等國家和地區
格隆匯5月7日丨立達信(605365.SH)在互動平臺表示,公司從事出口業務二十多年,產品遠銷全球50多個國家和地區,主要包括北美、歐洲、日本以及東南亞等國家和地區。自2018年美國加徵關稅以來,公司已逐步完善海外產能佈局,同時進一步開拓新的市場;公司除了出口業務,還以自有品牌開拓國內市場,形成多元化市場格局。關稅等外部環境的變化,可能對正常貿易秩序和消費者需求帶來衝擊。公司將努力提升業務和服務水平,爲消費者帶來解決本質需求的創新產品,增強議價能力,提升公司的競爭優勢和抗風險能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.